No Data
Executive Reshuffles: BIIB, USB and WES
New Study Reveals Another Benefit in Using Novo Nordisk's Wegovy in Obesity
Market Volatility Soars Ahead Of Elections, Tech Earnings Mixed, Strikes And Hurricanes Knock Employment Down: This Week In The Markets
Teva Presents Latest Schizophrenia Treatment Research, Including Phase 3 SOLARIS Trial Results Demonstrating Improvements In Social Functioning And Quality Of Life In Adults Receiving TEV-'749, A Subcutaneous Long-Acting Injectable As Well As Results...
Argenx Shares Are Trading Higher. Multiple Firms Raised Their Respective Price Targets on the Stock.
Argenx Q3 Revenue, EPS Beats Excite Bullish Biotech Analysts: 'Most Enviable I&I Pipeline In Entire Industry'